Re: If BP buys Apabetalone,...
|
7
|
Resverlogix Corp.
|
Nov 06, 2019 12:30PM
|
Re: Just back from IR,...
|
12
|
Resverlogix Corp.
|
Oct 25, 2019 11:20PM
|
Re: Kidney data rocks!
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 10:21PM
|
Re: MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 05, 2018 12:13PM
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 01:40PM
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 01:50PM
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 02:15PM
|
Re: MACE Event rate,....
|
2
|
Resverlogix Corp.
|
Feb 28, 2019 04:49PM
|
Re: MACE Event rate,....
|
2
|
Resverlogix Corp.
|
Feb 28, 2019 06:33PM
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Mar 01, 2019 05:05PM
|
Re: MACE Event rate,....
|
4
|
Resverlogix Corp.
|
Feb 28, 2019 12:19PM
|
Re: My general impressions
|
5
|
Resverlogix Corp.
|
Nov 16, 2019 04:11PM
|
Re: My general impressions
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 04:38PM
|
Re: My New Year's wish if for RVX to get a deal structured similarly to MYOV...
|
7
|
Resverlogix Corp.
|
Dec 29, 2020 05:08PM
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 12:29PM
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
5
|
Resverlogix Corp.
|
Nov 17, 2019 01:01PM
|
Re: No mention of efficacy again...
|
5
|
Resverlogix Corp.
|
Mar 27, 2019 01:44PM
|
Re: Not much happening these days regarding share price
|
4
|
Resverlogix Corp.
|
Apr 10, 2019 02:41PM
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 02:38PM
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 03:37PM
|